I think a safety comparison chart against competit
Post# of 148166
(Total Views: 240)
Posted On: 05/22/2019 11:05:15 AM
I think a safety comparison chart against competitors would be great. I don't see anything like this clearly listed on CYDY website, which I think is extremely important and one that makes leronlimab far superior to others....here is a pretty good one I copied from the EG article from a couple of months ago.
I also think a chart showing efficacy results across indications would be nice. Hopefully you receive CYDY's support and help get the word out to new patients and investors!
https://emerginggrowth.com/bio-path-nasdaq-bp...-analysis/
I also think a chart showing efficacy results across indications would be nice. Hopefully you receive CYDY's support and help get the word out to new patients and investors!
https://emerginggrowth.com/bio-path-nasdaq-bp...-analysis/
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼